NMPA Product

Compound Sulfadiazine Granules

Product approved by National Medical Products Administration (CN)

Basic Information

Product Name

Compound Sulfadiazine Granules

Generic Name

复方磺胺嘧啶颗粒

Strength

磺胺嘧啶0.4g,甲氧苄啶50mg

Dosage Form

颗粒剂

Regulatory Information

Approval Number

国药准字H13023703

Approval StatusApproved

Drug Type

化学药品

Approval Date

April 23, 2020

Company Information

Manufacturer神威药业集团有限公司

Production Company神威药业集团有限公司

Active Ingredients

Compound Sulfadiazine Granules

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy